Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lieberman

Showing results (1021-1030 of 1,142) with videos related to

Pageof 115
Sort By:
Neuroscience Letters|April 13, 2005
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophreniaDaniel J Müller, Tim A Klempan, Vincenzo De Luca, et al.
CA: a Cancer Journal for Clinicians|March 7, 2008
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyBernard Levin, David A Lieberman, Beth McFarland, et al.
The Journal of Clinical Psychiatry|March 29, 2008
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challengesW Wolfgang Fleischhacker, Marcelo Cetkovich-Bakmas, Marc De Hert, et al.
Archives of General Psychiatry|November 7, 2007
Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer diseaseRobert A Rosenheck, Douglas L Leslie, Jody L Sindelar, et al.
Schizophrenia Research|January 15, 2008
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2008
Extrapyramidal side-effects of antipsychotics in a randomised trialDel D Miller, Stanley N Caroff, Sonia M Davis, et al.
Archives of General Psychiatry|April 6, 2005
Antipsychotic drug effects on brain morphology in first-episode psychosisJeffrey A Lieberman, Gary D Tollefson, Cecil Charles, et al.
Schizophrenia Research|October 8, 2008
Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesiaClement C Zai, Marco A Romano-Silva, Rudi Hwang, et al.
The New England Journal of Medicine|September 21, 2005
Effectiveness of antipsychotic drugs in patients with chronic schizophreniaJeffrey A Lieberman, T Scott Stroup, Joseph P McEvoy, et al.
The Journal of Nervous and Mental Disease|March 15, 2006
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
Pageof 115

Showing results (1021-1030 of 1,142) with videos related to

Sort By:
Pageof 115
Neuroscience Letters|April 13, 2005
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophreniaDaniel J Müller, Tim A Klempan, Vincenzo De Luca, et al.
CA: a Cancer Journal for Clinicians|March 7, 2008
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of RadiologyBernard Levin, David A Lieberman, Beth McFarland, et al.
The Journal of Clinical Psychiatry|March 29, 2008
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challengesW Wolfgang Fleischhacker, Marcelo Cetkovich-Bakmas, Marc De Hert, et al.
Archives of General Psychiatry|November 7, 2007
Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer diseaseRobert A Rosenheck, Douglas L Leslie, Jody L Sindelar, et al.
Schizophrenia Research|January 15, 2008
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2008
Extrapyramidal side-effects of antipsychotics in a randomised trialDel D Miller, Stanley N Caroff, Sonia M Davis, et al.
Archives of General Psychiatry|April 6, 2005
Antipsychotic drug effects on brain morphology in first-episode psychosisJeffrey A Lieberman, Gary D Tollefson, Cecil Charles, et al.
Schizophrenia Research|October 8, 2008
Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesiaClement C Zai, Marco A Romano-Silva, Rudi Hwang, et al.
The New England Journal of Medicine|September 21, 2005
Effectiveness of antipsychotic drugs in patients with chronic schizophreniaJeffrey A Lieberman, T Scott Stroup, Joseph P McEvoy, et al.
The Journal of Nervous and Mental Disease|March 15, 2006
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
Pageof 115